Gene: ANKRD36C
Official Full Name: ankyrin repeat domain 36Cprovided by HGNC
Gene Summary: Predicted to enable ion channel inhibitor activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21398 | ANKRD36C Knockout cell line (HeLa) | Human | ANKRD36C | 1:3~1:6 | Negative | Online Inquiry |
KO21399 | ANKRD36C Knockout cell line (HCT 116) | Human | ANKRD36C | 1:2~1:4 | Negative | Online Inquiry |
KO21400 | ANKRD36C Knockout cell line (HEK293) | Human | ANKRD36C | 1:3~1:6 | Negative | Online Inquiry |
KO21401 | ANKRD36C Knockout cell line (A549) | Human | ANKRD36C | 1:3~1:4 | Negative | Online Inquiry |
ANKRD36C Gene Knockout Cell Lines represent a powerful tool for researchers focused on the functional analysis of the ANKRD36C gene, which is implicated in various biological processes and diseases. By employing CRISPR-Cas9 gene editing technology, these cell lines are engineered to disrupt the ANKRD36C gene, allowing scientists to study the effects of its absence in cellular environments. This targeted gene disruption provides a unique opportunity to unravel the role of ANKRD36C in cellular signaling pathways and its contributions to pathophysiological conditions.
The mechanism of action involves precise genome editing that generates frameshift mutations in the target gene, leading to the loss of protein function. This process not only enables researchers to observe resultant phenotypic changes but also facilitates the identification of potential compensatory mechanisms and molecular interactions associated with ANKRD36C. The generated knockout models can serve as valuable resources in drug discovery, gene function studies, and the investigation of gene-environment interactions.
Scientifically, ANKRD36C Gene Knockout Cell Lines hold immense importance in both research and clinical settings. They are pivotal for advancing our understanding of genetic contributions to diseases ranging from cancer to metabolic disorders. With this utility, researchers can better explore gene-targeted therapies and develop novel interventions, enhancing the precision of medical approaches.
Distinct advantages of these cell lines include their robust performance in various assays, reliable reproducibility, and compatibility with diverse experimental protocols. They offer a streamlined approach to study gene function without the confounding effects often seen with other methods, such as RNA interference. Furthermore, the use of CRISPR technology ensures high specificity and efficiency, which is a significant improvement over traditional gene silencing techniques.
For researchers and clinicians engaged in genetic and molecular studies, ANKRD36C Gene Knockout Cell Lines offer unparalleled value by enabling more accurate and timely insights into gene function and disease mechanisms. The potential insights gained from experiments using these cell lines could ultimately translate into innovative therapeutic strategies that address unmet clinical needs.
Our company is committed to providing high-quality, meticulously validated biological products that empower researchers in their quest for scientific advancement. With our deep expertise in gene editing technologies, we are dedicated to supporting the scientific community in unlocking new frontiers in genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.